TcrossGlobal

Prognostic impact of guideline-guided pharmacotherapy after FFR-guided revascularization defer: the J-CONFIRM registry.

The J-CONFIRM registry shows that patients with chronic coronary syndromes (CCS) who received FFR-guided revascularization followed by guideline-directed medical therapy (GDMT) had better outcomes than those who received suboptimal GDMT. Dr. Masanobu Ishii of Kumamoto University presented at the Hot-line Session of the 86th Annual Meeting of the Japanese Circulation Society.

The J-CONFIRM registry enrolled 1,263 patients (1,447 lesions) from 28 centers in Japan between Sept...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.